Update
05 May 2026
Update
Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that it will not be in a position to acquire another company or business by way of a reverse takeover on or before 10 May 2026, in accordance with AIM Rule 15. As a result, the Company will be suspended from trading on AIM pursuant to AIM Rule 40 with effect from 7:30 am on 11 May 2026.
As previously reported, the Board believes that there are potentially attractive acquisition opportunities available, and that as an AIM Rule 15 Cash Shell with surplus cash, the Company is well positioned to negotiate an accretive transaction which could increase Shareholder value. Although the Board is confident that a suitable acquisition can be identified within a reasonable timescale the Directors are taking time to carefully consider and evaluate all such approaches to ensure the most appropriate strategic option is chosen in the best interests of the Company and its Shareholders.
If the Company's shares remain suspended for six months, admission of the Company's shares will be cancelled. However, if the Company was to lose its AIM listing under AIM Rule 41 (i.e. the Company is unable to complete an acquisition in line with AIM Rule 15 by 11 November 2026) the Directors would fully explore seeking an alternative listing on the Aquis Stock Exchange in order to maintain an orderly market in the Ordinary Shares.
Following the recent share buybacks, and settlement of associated costs, the Company had cash (unaudited) of approximately £3.7m as at 30 April 2026.
For further information contact:
| Fortis Frontier PLC | www.fortisfrontierplc-ir.com |
| Adam Reynolds, Executive Chairman | via Walbrook PR |
| SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 |
| Neil Baldwin / Dillon Wall | |
| Singer Capital Markets (Broker) | Tel: +44 (0)20 7496 3000 |
| James Serjeant / Russell Cook / Amber Higgs | |
| Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com |
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44(0)7407 804 654 |
About Fortis Frontier PLC
On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.